Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CKC Mesenchymal Stem Cell-Derived Growth Factor and Cytokine Cream is an investigational topical biologic developed by CK Cell Technologies. The product is a cell-free formulation containing conditioned medium derived from mesenchymal stem cells (MSCs), which is rich in various growth factors and cytokines. Its mechanism of action relies on paracrine signaling to promote skin renewal, regeneration, and repair. It has been studied in a randomized, double-blind, placebo-controlled pilot trial to evaluate its safety and cosmetic efficacy for facial skin conditions in healthy female volunteers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CKC mesenchymal stem cell-derived growth factor and cytokine cream.